Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dialysis Symptom Control-Pruritus Outcome Trial: A Randomized Blinded Placebo Controlled Crossover Trial

NCT05180968 is registered in ClinicalTrials.gov with University of Manitoba as lead sponsor.

NCT NCT05180968
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05180968 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dialysis Symptom Control-Pruritus Outcome Trial: A Randomized Blinded Placebo Controlled Crossover Trial
Lead sponsor
University of Manitoba
Phase
Phase 3
Overall status
Completed
Start date
August 2, 2022
Completion date
August 11, 2023
Enrollment
14 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

end stage renal disease, pruritus